Back to IW Integrated Wealth Concepts LLC

ANTX

7 quarters

Position history for IWIntegrated Wealth Concepts LLC's holdings in AN2 Therapeutics, Inc.

No. Integrated Wealth Concepts exited its ANTX (AN2 Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 25,000 shares worth $26,500. Integrated Wealth Concepts first reported ANTX in Q2 2023 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$106,250

Total Shares Change

-12,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$1.27
0
2025-Q2
Unchanged
25,000
0.0%
$26,5000.0%$1.06
0
2025-Q1
Unchanged
25,000
0.0%
$34,0000.0%$1.36
0
2024-Q4
Unchanged
25,000
0.0%
$34,5000.0%$1.38
0
2024-Q3
New
25,000
-
$26,7500.0%$1.06
27
2023-Q3
Exited
0
-100.0%
$00.0%$16.08
0
2023-Q2
New
12,500
-
$106,2500.0%$8.40
30

Other major holders of ANTX: RA Capital Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used